199 related articles for article (PubMed ID: 21678333)
1. WITHDRAWN: Neoadjuvant cisplatin for advanced bladder cancer.
Advanced Bladder Cancer Meta-analysis Collaboration
Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD001426. PubMed ID: 21678333
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant cisplatin for advanced bladder cancer.
Advanced Bladder Cancer Overview Collaboration
Cochrane Database Syst Rev; 2000; (2):CD001426. PubMed ID: 10796791
[TBL] [Abstract][Full Text] [Related]
3. Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced Bladder Cancer Overview Collaboration.
Br J Urol; 1995 Feb; 75(2):206-13. PubMed ID: 7850328
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for invasive bladder cancer.
Advanced Bladder Cancer Overview Collaboration
Cochrane Database Syst Rev; 2005 Apr; 2004(2):CD005246. PubMed ID: 15846746
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy for locally advanced cervix cancer.
Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration
Cochrane Database Syst Rev; 2004; 2004(2):CD001774. PubMed ID: 15106161
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for invasive bladder cancer (individual patient data).
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD006018. PubMed ID: 16625650
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Burdett S; Pignon JP; Tierney J; Tribodet H; Stewart L; Le Pechoux C; Aupérin A; Le Chevalier T; Stephens RJ; Arriagada R; Higgins JP; Johnson DH; Van Meerbeeck J; Parmar MK; Souhami RL; Bergman B; Douillard JY; Dunant A; Endo C; Girling D; Kato H; Keller SM; Kimura H; Knuuttila A; Kodama K; Komaki R; Kris MG; Lad T; Mineo T; Piantadosi S; Rosell R; Scagliotti G; Seymour LK; Shepherd FA; Sylvester R; Tada H; Tanaka F; Torri V; Waller D; Liang Y;
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD011430. PubMed ID: 25730344
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for non-small cell lung cancer.
Non-small Cell Lung Cancer Collaborative Group
Cochrane Database Syst Rev; 2000; 2000(2):CD002139. PubMed ID: 10796867
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
Shelley M; Cleves A; Wilt TJ; Mason M
Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.
Stewart L;
Cochrane Database Syst Rev; 2000; (2):CD001418. PubMed ID: 10796788
[TBL] [Abstract][Full Text] [Related]
12. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials.
Advanced Bladder Cancer (ABC) Meta-analysis Collaborators Group
Eur Urol; 2022 Jan; 81(1):50-61. PubMed ID: 34802798
[TBL] [Abstract][Full Text] [Related]
14. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD008285. PubMed ID: 20091664
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for non-small cell lung cancer.
PORT Meta-Analysis Trialists Group
Cochrane Database Syst Rev; 2003; (1):CD002142. PubMed ID: 12535431
[TBL] [Abstract][Full Text] [Related]
16. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.
Rydzewska L; Tierney J; Vale CL; Symonds PR
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD007406. PubMed ID: 23235641
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for advanced gastric cancer.
Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for high-grade glioma.
Glioma Meta-Analysis Trialists (GMT) Group
Cochrane Database Syst Rev; 2002; (4):CD003913. PubMed ID: 12519620
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
